Related references
Note: Only part of the references are listed.IFNγ signaling integrity in colorectal cancer immunity and immunotherapy
Wan Du et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer
Ignasius Joanito et al.
NATURE GENETICS (2022)
Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status
Mehmet Akce et al.
FRONTIERS IN ONCOLOGY (2021)
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Mingyang Song et al.
GASTROENTEROLOGY (2020)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)
H. Lee et al.
ANNALS OF ONCOLOGY (2020)
Microbial Community Profiling Distinguishes Left-Sided and Right-Sided Colon Cancer
Mengya Zhong et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
Frank A. Sinicrope et al.
JNCI CANCER SPECTRUM (2020)
Immune modulatory effects of oncogenic KRAS in cancer
Shaima'a Hamarsheh et al.
NATURE COMMUNICATIONS (2020)
Intratumoural-infiltrating CD4+and FOXP3+T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
Taichi Kuwahara et al.
BRITISH JOURNAL OF CANCER (2019)
Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers
Yanglong Chen et al.
MEDICINE (2019)
Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair-Deficient Colon Cancers: Implications for Prognosis
Harry H. Yoon et al.
CLINICAL CANCER RESEARCH (2019)
Gut microbiota modulate T cell trafficking into human colorectal cancer
Eleonora Cremonesi et al.
GUT (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
A. Grothey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location
Longhui Zhang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status
Julien Taieb et al.
JAMA ONCOLOGY (2018)
Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer
Christopher G. Hurtado et al.
GASTROENTEROLOGY (2018)
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)
S. Rim Kim et al.
BRITISH JOURNAL OF CANCER (2018)
Differences Regarding the Molecular Features and Gut Microbiota Between Right and Left Colon Cancer
Kwangmin Kim et al.
ANNALS OF COLOPROCTOLOGY (2018)
Tumour-associated and non-tumour-associated microbiota in colorectal cancer
Burkhardt Flemer et al.
GUT (2017)
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
Julien Taieb et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
Julien Taieb et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials
Julian Walter Holch et al.
EUROPEAN JOURNAL OF CANCER (2017)
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer A Systematic Review and Meta-analysis
Fausto Petrelli et al.
JAMA ONCOLOGY (2017)
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer
Katsuhiko Nosho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
Kosuke Mima et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
Frank A. Sinicrope et al.
GASTROENTEROLOGY (2015)
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Kosuke Mima et al.
JAMA ONCOLOGY (2015)
Differential Expression of IL-17, 22 and 23 in the Progression of Colorectal Cancer in Patients with K-ras Mutation: Ras Signal Inhibition and Crosstalk with GM-CSF and IFN-γ
Savvas Petanidis et al.
PLOS ONE (2013)
Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma
Jahan S. Khalili et al.
CLINICAL CANCER RESEARCH (2012)
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer A Randomized Trial
Steven R. Alberts et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Prognostic Impact of FoxP3+Regulatory T Cells in Relation to CD8+T Lymphocyte Density in Human Colon Carcinomas
Harry H. Yoon et al.
PLOS ONE (2012)
Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
Nichole R. Blatner et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
Share Paper
